VetDC Featured in Dog Fancy Magazine

Company developing first canine lymphoma medicine

Hearing the news that a beloved dog has cancer is devastating, but fresh hope is on the horizon for dogs diagnosed with lymphoma, one of the most common canine cancers. VDC-1101, a targeted medicine designed specifically to treat canine lymphoma, is currently in development by Veterinary Emerging Technologies Company, or VetDC, a veterinary pharmaceutical startup in Fort Collins, Colorado. VDC-1101 is already creating a stir in the veterinary community due to its impressive results in clinical trials, says Steven Roy, president and CEO of VetDC.


To read the full text, view the image below.


DogFancy VetDC article Jan 2014